Lowe Devin B, Shearer Michael H, Kennedy Ronald C
Department of Microbiology and Immunology, Texas Tech University Health Sciences Center, Lubbock, 79430, USA.
J Cell Biochem. 2006 May 15;98(2):235-42. doi: 10.1002/jcb.20775.
Vaccination with plasmid DNA is an active area of investigation that is being applied to diseases including cancer and microbial pathogens associated with infectious diseases. Since its discovery, great progress has been made with the administration of DNA vaccines to initiate specific and effective immune responses against targeted illnesses. However, many obstacles still face its use in prophylactic and therapeutic vaccination scenarios. The nature of these difficulties alongside the successes and future of plasmid DNA will be discussed.
用质粒DNA进行疫苗接种是一个活跃的研究领域,正被应用于包括癌症以及与传染病相关的微生物病原体等疾病。自其被发现以来,在使用DNA疫苗引发针对特定疾病的特异性和有效免疫反应方面已取得了巨大进展。然而,在预防性和治疗性疫苗接种方案中使用它仍面临许多障碍。将讨论这些困难的本质以及质粒DNA的成功之处和未来发展。